Stephen Abreu

Stephen counsels biotechnology companies in their most critical strategic transactions, with a focus on complex intellectual property collaborations, licenses, acquisitions and cross-border partnerships.

In structuring and negotiating these matters for his clients, Stephen leverages his graduate scientific training as a molecular biologist and his experience leading monoclonal antibody research and development programs to translate scientific complexity into practical, business-focused deal terms.

Stephen has significant experience in university-industry transactions developed during his service as industry contracts manager at the University of California, San Francisco, for the Diabetes Center and the Immune Tolerance Network. In that role, he managed industry relationships between academic researchers in those departments and companies in biotechnology, pharmaceuticals and digital health, gaining insight into how academic discovery moves into commercial application.